DrugPatentWatch Database Preview
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE Drug Profile
Email this page to a colleague
» See Plans and PricingWhen do Fosinopril Sodium And Hydrochlorothiazide patents expire, and when can generic versions of Fosinopril Sodium And Hydrochlorothiazide launch?
Fosinopril Sodium And Hydrochlorothiazide is a drug marketed by Ani Pharms Inc, Aurobindo Pharma, Emcure Pharms Ltd, Invagen Pharms, Mylan, Sandoz, Sun Pharm Inds Ltd, and Teva. and is included in nine NDAs.
The generic ingredient in FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE is fosinopril sodium; hydrochlorothiazide. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the fosinopril sodium; hydrochlorothiazide profile page.
Summary for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 9 |
| Suppliers / Packagers: | 4 |
| Clinical Trials: | 2 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE at DailyMed |
Recent Clinical Trials for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ranbaxy Laboratories Limited | N/A |
See all FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE clinical trials
Pharmacology for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
| Drug Class | Angiotensin Converting Enzyme Inhibitor Thiazide Diuretic |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
| Physiological Effect | Increased Diuresis |
US Patents and Regulatory Information for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms Inc | FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | fosinopril sodium; hydrochlorothiazide | TABLET;ORAL | 076608-001 | Dec 3, 2004 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Teva | FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | fosinopril sodium; hydrochlorothiazide | TABLET;ORAL | 076945-002 | Jul 5, 2006 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Emcure Pharms Ltd | FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | fosinopril sodium; hydrochlorothiazide | TABLET;ORAL | 079025-001 | Sep 17, 2010 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
